Welcome to LookChem.com Sign In|Join Free
  • or
(R,S)-N-benzyloxycarbonyl-4-(1'-azido-ethyl)piperidine is a chemical with a specific purpose. Lookchem provides you with multiple data and supplier information of this chemical.

863560-17-2

Post Buying Request

863560-17-2 Suppliers

Recommended suppliers

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

863560-17-2 Usage

Check Digit Verification of cas no

The CAS Registry Mumber 863560-17-2 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 8,6,3,5,6 and 0 respectively; the second part has 2 digits, 1 and 7 respectively.
Calculate Digit Verification of CAS Registry Number 863560-17:
(8*8)+(7*6)+(6*3)+(5*5)+(4*6)+(3*0)+(2*1)+(1*7)=182
182 % 10 = 2
So 863560-17-2 is a valid CAS Registry Number.

863560-17-2Relevant academic research and scientific papers

4-SUBSTITUTED PIPERIDINE DERIVATIVES

-

Page/Page column 133-134, (2008/06/13)

Substituted piperidine compounds represented by the structure I are provided, wherein each of Rla, R1b, R1c, R1d, Rle, R1f, R1g, R1h, R2, R2A, R3, R4, A, X, a, x, and n is as defined in the specification. Substituted piperidine compounds of structure I may permeate or penetrate across a nerve cell membrane into the interior of a nerve cell, may inhibit intracellular Rho kinase enzyme found in nerve cells in mammals, and may find utility in repair of damaged nerves in the central and peripheral nervous system of such mammals. These compounds may induce the regeneration or growth of neurites in mammalian nerve cells and may thereby induce regeneration of damaged or diseased nerve tissue. These compounds also find additional utility as antagonists of the enzyme Rho kinase in treatment of disease states in which Rho kinase is implicated. Pharmaceutical compositions containing these substituted piperidine compounds may be useful to promote neurite growth and in the treatment of diseases in which Rho kinase inhibition is indicated.

Fibrinogen receptor antagonists

-

, (2008/06/13)

The present invention comprises fibrinogen receptor antagonist compounds, compositions containing them and methods for using them to inhibit fibrinogen binding to blood platelets. Compounds of the invention have the following formula STR1 wherein Z is STR

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1 Customer Service

What can I do for you?
Get Best Price

Get Best Price for 863560-17-2